Related Experiment Video
Updated: Jul 3, 2025

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
41.1K
Forces at play: exploring factors affecting the cancer metastasis
Farooq Riaz1, Jing Zhang2,3, Fan Pan1
1Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China.
Frontiers in Immunology
|February 16, 2024
Summary
Metastatic disease arises from tumor cell spread, often resisting treatment. Understanding the tumor microenvironment (TME) and its cellular players is key to developing new therapies for cancer metastasis.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Metastatic disease is a primary cause of cancer-related mortality.
- The tumor microenvironment (TME) significantly influences cancer progression and metastasis.
- Dissemination of tumor cells to distant sites leads to treatment failure and organ damage.
Purpose of the Study:
- To review pivotal tumor microenvironment (TME) components.
- To highlight how TME cell types and factors influence cancer metastasis.
- To provide background for developing targeted therapies against metastatic tumors.
Main Methods:
- Literature review of TME components and their roles in metastasis.
- Analysis of cellular players within the TME, including MSCs, LECs, CAFs, MDSCs, T cells, and TAMs.
- Examination of non-cellular factors like ECM, gut microbiota, circadian rhythm, and hypoxia.
Main Results:
- Various cell types (MSCs, LECs, CAFs, MDSCs, T cells, TAMs) are critical in cancer metastasis.
- Extracellular matrix, gut microbiota, circadian rhythm, and hypoxia also shape the TME and metastatic cascade.
- Understanding these TME components is essential for targeting metastatic tumors.
Conclusions:
- Targeting TME components offers a promising strategy for novel cancer therapies.
- Identifying molecular patterns of altered TME components can guide optimized treatment design.
- This review aids researchers in developing therapies to restrict the metastatic cascade and treat solid tumors.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K

